Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis

Transplant Proc. 1994 Dec;26(6):3622-3.

Authors

H P Lemmens¹, J M Langrehr, G Blumhardt, R Lohmann, M Knoop, J Verschl, N Schattenfroh, R Neuhaus, U Hopf, W O Bechstein, et al.

Affiliation

¹ Department of Surgery, University Hospital Rudolf Virchow, Free University of Berlin, Germany.

PMID: 7527983

No abstract available

Publication types

Comparative Study

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antilymphocyte Serum / therapeutic use
Azathioprine / therapeutic use
Cyclosporine / therapeutic use
Drug Administration Schedule
Graft Rejection / epidemiology
Graft Survival*
Hepatitis B / complications*
Hepatitis B Surface Antigens / blood*
Humans
Immunosuppression Therapy / methods*
Liver Failure / etiology
Liver Failure / surgery*
Liver Transplantation / immunology
Liver Transplantation / mortality
Liver Transplantation / physiology*
Postoperative Complications / epidemiology
Prednisolone / therapeutic use
Receptors, Interleukin-2 / immunology
Recurrence
Reoperation / statistics & numerical data
Retrospective Studies
Survival Rate
Tacrolimus / therapeutic use
Time Factors
Treatment Outcome

Substances

Antibodies, Monoclonal
Antilymphocyte Serum
Hepatitis B Surface Antigens
Receptors, Interleukin-2
Cyclosporine
Prednisolone
inolimomab
Azathioprine
Tacrolimus